查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1363271

血浆蛋白治疗市场规模、份额和趋势分析报告：按产品、按用途、按地区和细分趋势，2023-2030

Plasma Protein Therapeutics Market Size, Share & Trends Analysis Report By Product (Albumin, Immunoglobulin, Plasma-derived Factor VIII), By Application (Hemophilia, PID, ITP), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 86 Pages | 商品交期: 2-10个工作天内

价格

血浆蛋白治疗市场成长与趋势：

Grand View Research, Inc.的最新报告显示，到2030年，血浆蛋白治疗药物的全球市场规模预计将达到451亿美元，2023年至2030年的年复合成长率为6.1%。

这一增长的推动因素包括出血性疾病和其他罕见疾病的高患病、研发投资的增加以及血浆衍生产品在神经病学和其他治疗适应症中的使用增加。

血浆衍生蛋白主要用作治疗慢性罕见疾病的替代疗法。依赖这些药物的患者一生中需要定期注射或静脉输液。儘管有超过 250 种血浆衍生产品，但主要企业通常依赖免疫球蛋白 (IG)、白蛋白和凝血因子 VIII 来实现销售和盈利。

在过去的年度中，血浆蛋白治疗市场经历了显着的成长，其中免疫球蛋白占据了主要的市场占有率。对血浆衍生产品的需求是由疾病发病率上升、老年人口不断增加以及新兴市场获得药物的机会增加所推动的。新的血浆衍生治疗方法的核准预计将进一步推动需求。中国和巴西等新兴市场为全球市场巨头提供了新的投资途径。

血浆蛋白治疗市场报告亮点

  • 由于原发性免疫力缺乏的流行、新适应症的使用以及易于给药，因此对免疫球蛋白的需求预计将继续增加。
  • 在凝血因子 VIII 市场中，非血浆重组疗法可能会与血浆衍生产品竞争。
  • 原发性免疫力缺乏领域在 2022 年占据了最大的市场占有率，达到 26.5%，预计在预测期内将以 6.2% 的年复合成长率大幅增长。
  • 由于医疗保健支出增加、患者数量众多、患病患者与接受治疗的患者比例提高、药品生产成本低廉，预计亚太地区在 2022 年将占据最大市场占有率，达到 35.7%。由于诊断技术的改进，预测期内年复合成长率最快为 8.6%。

目录

第1章调查方法与范围

第2章执行摘要

第3章血浆蛋白治疗市场变数、趋势与范围

  • 市场体系预测
    • 母市场预测
    • 相关/附随市场预测
  • 普及和成长预测图
  • 市场动态
    • 市场促进因素分析
    • 市场抑制因素分析
  • 血浆蛋白治疗市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第4章血浆蛋白治疗药物市场：产品估算与趋势分析

  • 血浆蛋白治疗市场：重点
  • 血浆蛋白治疗市场：2022 年和 2030 年趋势和市场占有率分析
  • 白蛋白
  • 免疫球蛋白
  • 血浆衍生因子 VIII
  • 其他的

第5章血浆蛋白治疗药物市场：用途估算与趋势分析

  • 血浆蛋白治疗市场：重点
  • 血浆蛋白治疗市场：2022 年和 2030 年趋势和市场占有率分析
  • 血友病
  • 原发性免疫力缺乏症 (PID)
  • 特发性血小板减少紫斑症（ITP）
  • 其他的

第6章血浆蛋白治疗市场：区域估计与趋势分析

  • 区域展望
  • 按地区分類的血浆蛋白治疗市场：重点
  • 北美洲
    • 2018-2030 年市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第7章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 市场参与企业分类
    • CSL
    • Grifols, SA
    • Takeda
    • Octapharma AG
    • Biotest AG
    • Kedrion SpA
Product Code: GVR-2-68038-664-6

Plasma Protein Therapeutics Market Growth & Trends:

The global plasma protein therapeutics market size is expected to reach USD 45.1 billion by 2030, registering a CAGR of 6.1% from 2023 to 2030, according to a new report by Grand View Research, Inc.. The growth can be attributed to high prevalence of bleeding and other rare disorders, rising investment in R&D, and increasing use of plasma-derived products in neurology and other therapeutic indications.

Plasma-derived proteins are primarily used as replacement therapies to treat chronic, rare diseases. Patients that rely on these medications require regular injections or infusions throughout their lives. While there are more than 250 products derived from plasma, key players generally rely on Immunoglobulin (IG), albumin, and factor VIII to drive sales and profitability.

Over the past decade, the plasma protein therapeutics market has grown lucratively with immunoglobulin capturing the major market share. Demand for plasma derived-products is driven by rising disease prevalence, geriatric population, and improved access to drugs in emerging markets. Approvals of new plasma-derived therapies are anticipated to further fuel the demand. Developing countries such as China and Brazil offer new investment avenues to the global market giants.

Plasma Protein Therapeutics Market Report Highlights:

  • Demand for immunoglobulin is expected to continue rising owing to prevalence of primary immunodeficiencies, usage in new indications, and ease of administration
  • Non-plasma based recombinant therapies are likely to compete with plasma-derived products in the factor VIII market
  • The primary immunodeficiency diseases segment captured the largest market share of 26.5% in 2022 and is expected to exhibit substantial growth with a CAGR of 6.2% through the forecast period
  • Asia Pacific accounted for the largest market share of 35.7% in 2022 and is expected to exhibit the fastest CAGR of 8.6% over the forecast period fueled by increasing healthcare expenditure, presence of a large number of patients. improved ratio of patients suffering from disease and patients receiving treatment, low-cost production of drugs, and improvement in diagnostic technology.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Application
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Plasma Protein Therapeutics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Plasma Protein Therapeutics market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Plasma Protein Therapeutics market: Product Estimates & Trend Analysis

  • 4.1. Plasma Protein Therapeutics market: Key Takeaways
  • 4.2. Plasma Protein Therapeutics market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Albumin
    • 4.3.1. Albumin market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Immunoglobulin
    • 4.4.1. Immunoglobulin market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Plasma-derived Factor VIII
    • 4.5.1. Plasma-derived factor VIII market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Others
    • 4.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Plasma Protein Therapeutics market: Application Estimates & Trend Analysis

  • 5.1. Plasma Protein Therapeutics market: Key Takeaways
  • 5.2. Plasma Protein Therapeutics market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Hemophilia
    • 5.3.1. Hemophilia market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Primary Immunodeficiency Disorder (PID)
    • 5.4.1. Primary immunodeficiency disorder (PIDD) market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Idiopathic Thrombocytopenic Purpura (ITP)
    • 5.5.1. Idiopathic thrombocytopenic purpura (ITP) market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Plasma Protein Therapeutics market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Plasma Protein Therapeutics market by Region: Key Takeaways
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Denmark
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Norway
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. CSL
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Grifols, S.A.
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Takeda
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Octapharma AG
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Biotest AG
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Kedrion S.p.A
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 4 North America plasma protein therapeutics market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 6 U.S. plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 7 Canada plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 8 Canada plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 9 Europe plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 10 Europe plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 11 Europe plasma protein therapeutics market, by region, 2018 - 2030 (USD Million)
  • Table 12 Germany plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 13 Germany plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 14 UK plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 15 UK plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 16 France plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 17 France plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 18 Italy plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 19 Italy plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 20 Spain plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 21 Spain plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 22 Denmark plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 23 Denmark plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 24 Sweden plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 25 Sweden plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 26 Norway plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 27 Norway plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific plasma protein therapeutics market, by region, 2018 - 2030 (USD Million)
  • Table 31 Japan plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 32 Japan plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 33 China plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 34 China plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 35 India plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 36 India plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 37 Australia plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 38 Australia plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 39 Thailand plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 40 Thailand plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 41 South Korea plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 42 South Korea plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 43 Latin America plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 44 Latin America plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 45 Latin America plasma protein therapeutics market, by region, 2018 - 2030 (USD Million)
  • Table 46 Brazil plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 47 Brazil plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 48 Mexico plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 49 Mexico plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 50 Argentina plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 51 Argentina plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa plasma protein therapeutics market, by region, 2018 - 2030 (USD Million)
  • Table 55 South Africa plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 56 South Africa plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 59 UAE plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 60 UAE plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 61 Kuwait plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 62 Kuwait plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Plasma protein therapeutics: Market outlook
  • Fig. 9 Plasma protein therapeutics: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Plasma protein therapeutics market driver impact
  • Fig. 15 Plasma protein therapeutics market restraint impact
  • Fig. 16 Plasma protein therapeutics market strategic initiatives analysis
  • Fig. 17 Plasma protein therapeutics market: Product movement analysis
  • Fig. 18 Plasma protein therapeutics market: Product outlook and key takeaways
  • Fig. 19 Albumin market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Immunoglobulin market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Factor VIII market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Plasma protein therapeutics market: Application movement analysis
  • Fig. 23 Plasma protein therapeutics market: Application outlook and key takeaways
  • Fig. 24 Hemophilia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Primary immunodeficiency disorder (PIDD) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Idiopathic thrombocytopenic purpura (ITP) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Global plasma protein therapeutics market: Regional movement analysis
  • Fig. 29 Global plasma protein therapeutics market: Regional outlook and key takeaways
  • Fig. 30 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)